Search Results - Klearman, Micki

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Development and Implementation of a Double-Blind Corticosteroid-Tapering Regimen for a Clinical Trial

    Development and Implementation of a Double-Blind Corticosteroid-Tapering Regimen for a Clinical Trial by Collinson, Neil, Tuckwell, Katie, Habeck, Frank, Chapman, Monique, Klearman, Micki, Stone, John H.

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA)

    Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA) by Bingham, Clifton O, Rizzo, Warren, Kivitz, Alan, Hassanali, Azra, Upmanyu, Ruchi, Klearman, Micki

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial

    Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial by Strand, Vibeke, Dimonaco, Sophie, Tuckwell, Katie, Klearman, Micki, Collinson, Neil, Stone, John H.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis

    Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis by Gabay, Cem, McInnes, Iain B, Kavanaugh, Arthur, Tuckwell, Katie, Klearman, Micki, Pulley, Jennifer, Sattar, Naveed

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi‐Database Cohort Study

    Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi‐Database Cohort Study by Kim, Seoyoung C., Solomon, Daniel H., Rogers, James R., Gale, Sara, Klearman, Micki, Sarsour, Khaled, Schneeweiss, Sebastian

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Glucocorticoid Dosages and Acute‐Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab

    Glucocorticoid Dosages and Acute‐Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab by Stone, John H., Tuckwell, Katie, Dimonaco, Sophie, Klearman, Micki, Aringer, Martin, Blockmans, Daniel, Brouwer, Elisabeth, Cid, Maria C., Dasgupta, Bhaskar, Rech, Juergen, Salvarani, Carlo, Schulze‐Koops, Hendrik, Schett, Georg, Spiera, Robert, Unizony, Sebastian H., Collinson, Neil

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics

    Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics by Dennis, Glynn, Holweg, Cécile TJ, Kummerfeld, Sarah K, Choy, David F, Setiadi, A Francesca, Hackney, Jason A, Haverty, Peter M, Gilbert, Houston, Lin, Wei Yu, Diehl, Lauri, Fischer, S, Song, An, Musselman, David, Klearman, Micki, Gabay, Cem, Kavanaugh, Arthur, Endres, Judith, Fox, David A, Martin, Flavius, Townsend, Michael J

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: